Meta-analysis of mNGF therapy for peripheral nerve

【Abstract】Objective: To assess the efficacy and safety of mouse nerve growth factor (mNGF) in patients with peripheral nerve injury. Methods: Such electronic database as Cochrane Li-brary (Issue 1, 2011), Medline (1950-2011), Embase (1980-2011), National Knowledge Infrastructure (1979-2011)...

Full description

Bibliographic Details
Main Authors: LIU Yan-rong, LIU Qiang
Format: Article
Language:English
Published: Elsevier 2012-04-01
Series:Chinese Journal of Traumatology
Online Access:http://www.cjtrauma.com/apps/ojs/index.php/cjt/article/view/205
id doaj-f99194c028914c6e9f9e133b48e20dc9
record_format Article
spelling doaj-f99194c028914c6e9f9e133b48e20dc92020-11-24T22:53:29ZengElsevierChinese Journal of Traumatology1008-12752012-04-011528691126Meta-analysis of mNGF therapy for peripheral nerveLIU Yan-rongLIU Qiang【Abstract】Objective: To assess the efficacy and safety of mouse nerve growth factor (mNGF) in patients with peripheral nerve injury. Methods: Such electronic database as Cochrane Li-brary (Issue 1, 2011), Medline (1950-2011), Embase (1980-2011), National Knowledge Infrastructure (1979-2011) were searched and meanwhile relevant journals such as Chinese Journal of Orthopaedics, Chinese Journal of Microsurgery, Chinese Journal of Neurosurgery, etc were searched as well to collect all randomized controlled trials and quasi-randomi-zed controlled trials of mNGF on patients with peripheral nerve injury. The quality of included studies was assessed according to the criteria recommended by the Cochrane Handbook for Systematic Reviews of Interventions and the data were extracted by two reviewers independently. Meta-analysis was conducted by RevMan 5.1 software. Results: Forty-one studies involving 3 304 patients with peripheral nerve injury were included. The results of meta-analysis showed that: (1) the total effective rate of peripheral nerve injury treatment in mNGF group was ob-viously higher than that in control group (OR=6.36, 95% CI 4.96-8.15, P<0.01); (2) the scores of activities of daily living (ADL) in mNGF group was significantly higher than that in control group (weighted mean difference=1.97, 95% CI 1.33-2.61, P<0.01); (3) the incidence of adverse reaction in mNGF group was higher than that in control group, (OR=1.66, 95% CI 1.61-2.38, P=0.006), but the adverse effects were mild, which could be relieved without specific treatment or just given symptomatic treatment, and disappeared at the end of treatment. Conclusions: The mNGF therapy is effective for pe-ripheral nerve injury. It can obviously improve patient’s ADL. Though the incidence of adverse reaction in mNGF treatment group is higher than that in control group, this does not influence the treatment outcomes. Key words: Peripheral nerves; Nerve growth factor; Randomized controlled trial; Meta-analysishttp://www.cjtrauma.com/apps/ojs/index.php/cjt/article/view/205
collection DOAJ
language English
format Article
sources DOAJ
author LIU Yan-rong
LIU Qiang
spellingShingle LIU Yan-rong
LIU Qiang
Meta-analysis of mNGF therapy for peripheral nerve
Chinese Journal of Traumatology
author_facet LIU Yan-rong
LIU Qiang
author_sort LIU Yan-rong
title Meta-analysis of mNGF therapy for peripheral nerve
title_short Meta-analysis of mNGF therapy for peripheral nerve
title_full Meta-analysis of mNGF therapy for peripheral nerve
title_fullStr Meta-analysis of mNGF therapy for peripheral nerve
title_full_unstemmed Meta-analysis of mNGF therapy for peripheral nerve
title_sort meta-analysis of mngf therapy for peripheral nerve
publisher Elsevier
series Chinese Journal of Traumatology
issn 1008-1275
publishDate 2012-04-01
description 【Abstract】Objective: To assess the efficacy and safety of mouse nerve growth factor (mNGF) in patients with peripheral nerve injury. Methods: Such electronic database as Cochrane Li-brary (Issue 1, 2011), Medline (1950-2011), Embase (1980-2011), National Knowledge Infrastructure (1979-2011) were searched and meanwhile relevant journals such as Chinese Journal of Orthopaedics, Chinese Journal of Microsurgery, Chinese Journal of Neurosurgery, etc were searched as well to collect all randomized controlled trials and quasi-randomi-zed controlled trials of mNGF on patients with peripheral nerve injury. The quality of included studies was assessed according to the criteria recommended by the Cochrane Handbook for Systematic Reviews of Interventions and the data were extracted by two reviewers independently. Meta-analysis was conducted by RevMan 5.1 software. Results: Forty-one studies involving 3 304 patients with peripheral nerve injury were included. The results of meta-analysis showed that: (1) the total effective rate of peripheral nerve injury treatment in mNGF group was ob-viously higher than that in control group (OR=6.36, 95% CI 4.96-8.15, P<0.01); (2) the scores of activities of daily living (ADL) in mNGF group was significantly higher than that in control group (weighted mean difference=1.97, 95% CI 1.33-2.61, P<0.01); (3) the incidence of adverse reaction in mNGF group was higher than that in control group, (OR=1.66, 95% CI 1.61-2.38, P=0.006), but the adverse effects were mild, which could be relieved without specific treatment or just given symptomatic treatment, and disappeared at the end of treatment. Conclusions: The mNGF therapy is effective for pe-ripheral nerve injury. It can obviously improve patient’s ADL. Though the incidence of adverse reaction in mNGF treatment group is higher than that in control group, this does not influence the treatment outcomes. Key words: Peripheral nerves; Nerve growth factor; Randomized controlled trial; Meta-analysis
url http://www.cjtrauma.com/apps/ojs/index.php/cjt/article/view/205
work_keys_str_mv AT liuyanrong metaanalysisofmngftherapyforperipheralnerve
AT liuqiang metaanalysisofmngftherapyforperipheralnerve
_version_ 1725663244862881792